The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity
Yang Woon Lee, Kang-Moon Lee, Ji Min Lee, Yoon Yung Chung, Dae Bum Kim, Yeon Ji Kim, Woo Chul Chung, Chang-Nyol Paik
Korean J Intern Med. 2019;34(1):72-80.   Published online 2018 Jan 20     DOI: https://doi.org/10.3904/kjim.2016.324
Citations to this article as recorded by Crossref logo
Fecal calprotectin in daily practice for patients with inflammatory bowel disease: where do we stand in Korea?
Jae Myung Cha
The Korean Journal of Internal Medicine.2019; 34(1): 60.     CrossRef
From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting
Maria Gloria Mumolo, Lorenzo Bertani, Linda Ceccarelli, Gabriella Laino, Giorgia Di Fluri, Eleonora Albano, Gherardo Tapete, Francesco Costa
World Journal of Gastroenterology.2018; 24(33): 3681.     CrossRef
Recent advances in ankylosing spondylitis: understanding the disease and management
Leticia Garcia-Montoya, Hanna Gul, Paul Emery
F1000Research.2018; 7: 1512.     CrossRef